November 24, 2016 - By Ruchi Gupta · 0 Comments
Express Scripts Holding Co (NASDAQ:ESRX) institutional sentiment decreased to 0.64 in Q2 2016. Its down -0.02, from 0.66 in 2016Q1. The ratio worsened, as 379 funds started new and increased positions, while 576 cut down and sold their stock positions in Express Scripts Holding Co. The funds in our partner’s database now own: 548.60 million shares, down from 564.74 million shares in 2016Q1. Also, the number of funds holding Express Scripts Holding Co in their top 10 positions increased from 39 to 42 for an increase of 3. Sold All: 73 Reduced: 503 Increased: 301 New Position: 78.
The stock increased 1.16% or $0.88 on November 23, hitting $76.81. About 2.24 million shares traded hands. Express Scripts Holding Company (NASDAQ:ESRX) has risen 4.43% since April 22, 2016 and is uptrending. It has underperformed by 0.98% the S&P500.
Analysts await Express Scripts Holding Company (NASDAQ:ESRX) to report earnings on February, 21. They expect $1.87 earnings per share, up 19.87% or $0.31 from last year’s $1.56 per share. ESRX’s profit will be $1.14 billion for 10.27 P/E if the $1.87 EPS becomes a reality. After $1.74 actual earnings per share reported by Express Scripts Holding Company for the previous quarter, Wall Street now forecasts 7.47% EPS growth.
According to Zacks Investment Research, “Express Scripts, Inc. is one of the largest pharmacy benefit management companies in North America. Through facilities in the states and Canada, the company serves thousands of client groups, including managed care organizations, insurance carriers, third-party administrators, employers and union-sponsored benefit plans.”
Chieftain Capital Management Inc. holds 16.62% of its portfolio in Express Scripts Holding Company for 4.17 million shares. Green Valley Investors Llc owns 6.96 million shares or 16.14% of their US portfolio. Moreover, Riverhead Capital Management Llc has 16.14% invested in the company for 6.96 million shares. The Missouri-based Cortland Associates Inc Mo has invested 12.48% in the stock. Bloombergsen Inc., a Ontario – Canada-based fund reported 1.40 million shares.#img1#
Ratings analysis reveals 40% of Express Scripts’s analysts are positive. Out of 15 Wall Street analysts rating Express Scripts, 6 give it “Buy”, 2 “Sell” rating, while 7 recommend “Hold”. The lowest target is $61 while the high is $96. The stock’s average target of $82.58 is 7.51% above today’s ($76.81) share price. ESRX was included in 23 notes of analysts from July 30, 2015. On Thursday, July 30 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm has “Hold” rating by Deutsche Bank given on Friday, November 4. The stock has “Market Perform” rating given by Leerink Swann on Wednesday, March 23. As per Thursday, February 18, the company rating was maintained by Barclays Capital. On Monday, February 22 the stock rating was downgraded by Deutsche Bank to “Sell”. The stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Outperform” rating by Leerink Swann on Monday, October 5. As per Thursday, June 16, the company rating was initiated by Bernstein. The stock of Express Scripts Holding Company (NASDAQ:ESRX) has “Market Perform” rating given on Tuesday, January 19 by Leerink Swann. As per Tuesday, June 7, the company rating was maintained by Bank of America. The firm has “Outperform” rating given on Tuesday, April 26 by Credit Suisse.
Express Scripts Holding Company, incorporated on July 15, 2011, is a pharmacy benefit management (PBM) firm in the United States. The Firm is engaged in providing healthcare management and administration services to its clients, including managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. The Firm has two business divisions, which include PBM and Other Business Operations. The PBM segment includes its integrated PBM activities and specialty pharmacy operations. The Company’s Other Business Operations segment includes United BioSource Corporation (UBC) and its specialty distribution operations.
More news for Express Scripts Holding Company (NASDAQ:ESRX) were recently published by: Fool.com, which released: “Express Scripts Holding Company Q3 Results: What You Need to Know” on October 25, 2016. Prnewswire.com‘s article titled: “Express Scripts to Present at the Credit Suisse Healthcare Conference” and published on November 01, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Ruchi Gupta